|Azithromycin||Macrolide antibacterial||Film-coated tablets||500 mg|
|Azithromycin||Macrolide antibacterial||Powder for oral suspension||200 mg/5 ml|
|Ciprofloxacin otic||Otitis||Ear drops, solution (unit dose)||1 mg|
|Fluconazol||Antifungal||Hard capsules||50, 100, 150 and 200 mg|
|Fluconazol||Antifungal||Powder for oral suspension||200 mg/5ml|
[*] Differentiated product
Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.
© Neuraxpharm / LESVI. All rights reserved.